Simulations Plus third-quarter consolidated preliminary revenues up 14.9% to $3.1M

NewsGuard 100/100 Score

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today released preliminary revenues for its third fiscal quarter ended May 31, 2010.

“I will be presenting at the Sidoti Micro-Cap Investor Conference in New York City on Friday, June 25, and I'll be doing a series of investor 'road shows' in Manhattan the day before”

Ms. Momoko Beran, chief financial officer of Simulations Plus, stated, "Although it is not our policy to announce preliminary revenues, we are doing so for this quarter because our CEO, Walt Woltosz, will be speaking at the Sidoti Micro-Cap Investor Conference in New York this week, and we want to be able to provide the most current information possible."

Preliminary results for the quarter:

  • Consolidated preliminary revenues for the third fiscal quarter of the 2010 fiscal year were $3.1 million, a new record.
  • This represents an increase of 14.9% compared to last year's third quarter.
  • Preliminary revenues for the pharmaceutical software and services portion of the business were up 17.1% to $2.3 million.
  • Preliminary revenues for the Words+ subsidiary were $794,000, an increase of 9.1% over last year's third quarter.

"Earnings will not be known until income taxes have been determined and our auditors review our Quarterly Report on Form 10Q for the third quarter of 2010, which we expect to file with the SEC in mid-July," Ms. Beran continued.

Walt Woltosz, chairman and chief executive officer of Simulations Plus, added, "This is our first quarter with over $3 million in sales, and it's gratifying to see nice increases not only in the revenues from our pharmaceutical software and services business, but also in the Words+ subsidiary. We believe the aggressive marketing and sales program initiated last year is clearly resulting in improved financial performance, and we continue to benefit from the pharmaceutical industry's shift toward the increased utilization of simulation and modeling tools to increase productivity."

"I will be presenting at the Sidoti Micro-Cap Investor Conference in New York City on Friday, June 25, and I'll be doing a series of investor 'road shows' in Manhattan the day before," Mr. Woltosz continued. "Although we are providing preliminary revenues for the third quarter prior to the 10-Q filing because of those meetings this week, preliminary revenues releases should not be expected every quarter."

Simulations Plus expects to announce its third fiscal quarter results and file its Quarterly Report on Form 10-Q in mid-July 2010.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fight